CT
Contineum Therapeutics, Inc. (CTNM)
NASDAQ·Healthcare·Biotechnology
$15.37
-3.52%
Mkt Cap $582.75M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
+4.1%
Consensus $16.00 vs current $15.37
NASDAQ·Healthcare·Biotechnology
$15.37
-3.52%
Mkt Cap $582.75M
Buy
2
Hold
1
Sell
0
Price Target (9 analysts)
$16.00
Range $16.00 – $16.00
+4.1%
Consensus $16.00 vs current $15.37